US FDA – Page 20 – Express Pharma

COVID vaccines for kids between five and 11 likely in November: Fauci

FDA approves Roche’s Susvimo for neovascular or “wet” age-related macular degeneration (nAMD)

Biocon Biologics and Viatris’s Semglee preferred on Express Scripts’ largest formulary in US

FDA takes additional actions on use of booster dose for COVID-19 vaccines

Roche Pharma achieves several milestones in Q3

Pfizer/BioNTech submit data to EMA for children’s COVID-19 vaccine

US FDA advisers to review Merck’s Molnupiravir soon

FDA approves Verzenio as the first and only CDK4/6 inhibitor for certain people with HR+HER2- high-risk early breast cancer

Merck and Ridgeback seek Emergency Use Authorisation from US FDA for Molnupiravir

US FDA grants breakthrough therapy designation to Roche’s anti-amyloid beta antibody gantenerumab